首页> 外文期刊>American Journal of Transplantation >No-Touch Hepatic Hilum Technique to Treat Early Portal Vein Thrombosis After Pediatric Liver Transplantation
【24h】

No-Touch Hepatic Hilum Technique to Treat Early Portal Vein Thrombosis After Pediatric Liver Transplantation

机译:非接触式肝门技术治疗小儿肝移植后早期门静脉血栓形成

获取原文
获取原文并翻译 | 示例
           

摘要

A ‘no-touch’ hilum technique used to treat early portal vein complications post-liver transplantation in five children with body weight <10 kg is described. Four patients developed thrombosis and one portal flow absence secondary to collateral steal flow. A vascular sheath was placed through the previous laparotomy in the ileocolic vein (n = 2), inferior mesenteric vein (n = 1) or graft umbilical vein (n = 1). Portal clots were mechanically fragmented with balloon angioplasty. In addition, coil embolization of competitive collaterals (n = 3) and stent placement (n = 1) were performed. The catheter was left in place and exteriorized through the wound (n = 2) or a different transabdominal wall puncture (n = 3). A continuous transcatheter perfusion of heparin was subsequently administered. One patient developed recurrent thrombosis 24 h later which was resolved with the same technique. Catheters were removed surgically after a mean of 10.6 days. All patients presented portal vein patency at the end of follow-up. Three patients are alive after 5 months, 1.5 and 3.5 years, respectively; one patient required retransplantation 18 days postprocedure and the remaining patient died of adenovirus infection 2 months postprocedure. In conclusion, treatment of early portal vein complications following pediatric liver transplantation with this novel technique is feasible and effective.
机译:描述了一种“非接触式”肺门技术,用于治疗5名体重<10 kg的儿童在肝移植后的早期门静脉并发症。四名患者发生了血栓形成,另一名门静脉血流继发于旁侧盗血。通过先前的剖腹术将血管鞘放置在回盲静脉(n = 2),肠系膜下静脉(n = 1)或移植脐带静脉(n = 1)中。用球囊血管成形术机械破碎门静脉血块。此外,进行了竞争性侧支的线圈栓塞(n = 3)和支架置入(n = 1)。将导管留在原处,并通过伤口(n = 2)或不同的经腹壁穿刺(n = 3)使其外部化。随后进行肝素的连续经导管灌注。一名患者在24小时后出现了复发性血栓形成,采用相同的技术即可解决。平均10.6天后,通过外科手术切除导管。随访结束时所有患者均出现门静脉通畅。 3例分别在5个月,1.5和3。5年后还活着;一名患者需要在术后18天进行再移植,其余患者在术后2个月内死于腺病毒感染。总之,用这种新技术治疗小儿肝移植术后早期门静脉并发症是可行和有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号